Conference Material
|
Abstract
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis
Arana B,
Lopez L,
Velez ID,
Llanos-Cuentas A,
Boni MF,
Rode J
View HTML
View PDF
Share
Download
Download
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
Abstract
Countries
Colombia
Peru
Subject Area
neglected tropical diseases
cutaneous leishmaniasis
Languages
English
Published Date
13 May 2020
Conference
MSF Scientific Days International 2020: Research
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis | Conference Material / Abstract | MSF Science Portal
